(UroToday.com) Dr Rovner moderated a symposium on Bulkamid®, a periurethral injection which was approved by the FDA in 2020 for the treatment of stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD) or in women who have SUI or stress predominant mixed urinary incontinence (UI). It is now the leading bulking agent in Europe, Australia, and Canada and the #1 treatment procedure in the UK.